Incidence of organ-specific irAEs depending on HLA-A*02:01 status. In total, 97 patients with metastatic melanoma were investigated regarding the development of immune-related adverse events (irAEs) undergoing immune checkpoint inhibitor treatment, comparing HLA-A*02:01-positive and -negative patients. In total, 24 patients irHepatitis